SCHEMBL6289038

SCHEMBL6289038

COc1cc(CNC(=O)CO)cc(OC)c1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 1/20 0.60
▸ KMT2A Q03164 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ EPHX2 P34913 2/20 0.47
▸ ERCC1 P07992 1/20 0.47
▸ ERCC4 Q92889 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ MMP13 P45452 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6289037 0.86 TACR1 (0.60) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL14672755 0.86 TACR1 (0.60) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL2341547 0.81 TACR1 (0.59) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL5670829 0.81 TACR1 (0.55) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL5340479 0.80 TACR1 (0.54) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL13306937 0.79 TACR1 (0.52) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL19373061 0.77 TACR1 (0.51) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL14521466 0.77 KMT2A (0.57) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL28062787 0.77 TACR1 (0.51) TACR1KMT2AMEN1ALDH1A1HTT
SCHEMBL13257582 0.77 ALDH1A1 (0.65) TACR1ALDH1A1POLBERCC1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867200-B1 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-15 — — US disclosed
Send feedback